Yew Bio-Pharm Group, Inc.
YEWB · OTC
12/31/2020 | 12/31/2019 | 12/31/2018 | 12/31/2017 | |
|---|---|---|---|---|
| Market Cap | $5,687 | $3,882 | $12,472 | $10,116 |
| - Cash | $564 | $742 | $522 | $860 |
| + Debt | $9,338 | $8,945 | $5,759 | $6,100 |
| Enterprise Value | $14,461 | $12,085 | $17,709 | $15,356 |
| Revenue | $27,308 | $27,884 | $37,597 | $40,540 |
| % Growth | -2.1% | -25.8% | -7.3% | – |
| Gross Profit | $3,527 | $774 | $10,724 | $5,062 |
| % Margin | 12.9% | 2.8% | 28.5% | 12.5% |
| EBITDA | $4,777 | $1,208 | $19,766 | $3,325 |
| % Margin | 17.5% | 4.3% | 52.6% | 8.2% |
| Net Income | $1,465 | $986 | -$1,322 | $3,213 |
| % Margin | 5.4% | 3.5% | -3.5% | 7.9% |
| EPS Diluted | 0.03 | 0.02 | -0.025 | 0.06 |
| % Growth | 50% | 178.7% | -142.3% | – |
| Operating Cash Flow | $17,340 | $11,954 | $32,467 | -$2,620 |
| Capital Expenditures | -$17,356 | -$14,682 | -$32,800 | -$799 |
| Free Cash Flow | -$16 | -$2,728 | -$333 | -$3,419 |